Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07018947 |
| Title | Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC (ASPIRE) |
| Acronym | ASPIRE |
| Recruitment | Not yet recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Fundacion Clinic per a la Recerca Biomédica |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | ESP |